BACKGROUND: The objective of our study was to examine cardiologists' and organizational leaders' interest in clinical trial participation and perceived barriers and facilitators to participation within ten diverse non-profit healthcare delivery systems. Trials play a pivotal role in advancing knowledge about the safety and efficacy of cardiovascular interventions and tests. Although cardiovascular trials successfully enroll patients, recruitment challenges persist. Community-based health systems could be an important source of participants and investigators, but little is known about community cardiologists' experiences with trials. METHODS: We interviewed 25 cardiology and administrative leaders and mailed questionnaires to all 280 cardiologists at 10 U.S. healthcare organizations. RESULTS: The survey received a 73% response rate. While 60% of respondents had not participated in any trials in the past year, nearly 75% wanted greater participation. Cardiologists reported positive attitudes toward trial participation; more than half agreed that trials were their first choice of therapy for patients, if available. Almost all leaders described their organizations as valuing research but not necessarily trials. Major barriers to participation were lack of physician time and insufficient skilled research nurses. CONCLUSIONS: Cardiologists have considerable interest in trial participation. Major obstacles to increased participation are lack of time and effective infrastructure to support trials. These results suggest that community-based health systems are a rich source for cardiovascular research but additional funding and infrastructure are needed to leverage this resource.
BACKGROUND: The objective of our study was to examine cardiologists' and organizational leaders' interest in clinical trial participation and perceived barriers and facilitators to participation within ten diverse non-profit healthcare delivery systems. Trials play a pivotal role in advancing knowledge about the safety and efficacy of cardiovascular interventions and tests. Although cardiovascular trials successfully enroll patients, recruitment challenges persist. Community-based health systems could be an important source of participants and investigators, but little is known about community cardiologists' experiences with trials. METHODS: We interviewed 25 cardiology and administrative leaders and mailed questionnaires to all 280 cardiologists at 10 U.S. healthcare organizations. RESULTS: The survey received a 73% response rate. While 60% of respondents had not participated in any trials in the past year, nearly 75% wanted greater participation. Cardiologists reported positive attitudes toward trial participation; more than half agreed that trials were their first choice of therapy for patients, if available. Almost all leaders described their organizations as valuing research but not necessarily trials. Major barriers to participation were lack of physician time and insufficient skilled research nurses. CONCLUSIONS: Cardiologists have considerable interest in trial participation. Major obstacles to increased participation are lack of time and effective infrastructure to support trials. These results suggest that community-based health systems are a rich source for cardiovascular research but additional funding and infrastructure are needed to leverage this resource.
Authors: Paul W Armstrong; L Kristin Newby; Christopher B Granger; Kerry L Lee; R John Simes; Frans Van de Werf; Harvey D White; Robert M Califf Journal: Circulation Date: 2004-12-07 Impact factor: 29.690
Authors: Robert M Davidson; J Frederick McNeer; Leanne Logan; Michael B Higginbotham; Jerome Anderson; Joseph Blackshear; Alan Chu; Bruce Hettleman; Frank McGrew; Roderick Meesse; Christopher O'Connor; Ricky Schneider; Galen S Wagner Journal: Am Heart J Date: 2006-02 Impact factor: 4.749
Authors: E J Topol; R M Califf; F Van de Werf; M Simoons; J Hampton; K L Lee; H White; J Simes; P W Armstrong Journal: Circulation Date: 1997-02-18 Impact factor: 29.690
Authors: Carol P Somkin; Andrea Altschuler; Lynn Ackerson; Ann M Geiger; Sarah M Greene; Judy Mouchawar; Joan Holup; Louis Fehrenbacher; Andrew Nelson; Andrew Glass; Jonathan Polikoff; Sigrid Tishler; Carolyn Schmidt; Terry Field; Edward Wagner Journal: Am J Manag Care Date: 2005-07 Impact factor: 2.229
Authors: David E Kandzari; Matthew T Roe; Anita Y Chen; Barbara L Lytle; Charles V Pollack; Robert A Harrington; E Magnus Ohman; W Brian Gibler; Eric D Peterson Journal: Am Heart J Date: 2005-03 Impact factor: 4.749
Authors: Duika L Burges Watson; Randy Sanoff; Joan E Mackintosh; Jeffrey L Saver; Gary A Ford; Christopher Price; Sidney Starkman; Marc Eckstein; Robin Conwit; Anna Grace; Madeleine J Murtagh Journal: Ann Emerg Med Date: 2012-03-03 Impact factor: 5.721
Authors: Susan Eggly; Lauren M Hamel; Elisabeth Heath; Mark A Manning; Terrance L Albrecht; Ellen Barton; Mark Wojda; Tanina Foster; Michael Carducci; Dina Lansey; Ting Wang; Rehab Abdallah; Narineh Abrahamian; Seongho Kim; Nicole Senft; Louis A Penner Journal: BMC Cancer Date: 2017-12-02 Impact factor: 4.430
Authors: Marcus R Johnson; Tawni Kenworthy-Heinige; Danielle J Beck; Aliya Asghar; Emily B Broussard; Karen Bratcher; Lynn M Tommessilli; Margaret Antonelli; Beata M Planeta Journal: Contemp Clin Trials Commun Date: 2018-02-03